Coinbase Founder’s Longevity Startup Triples in Value

Date:




Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Buccaneers’ Godwin ‘didn’t believe’ news of Evans’ exit at first

Jenna LaineJun 2, 2026, 05:06 PM ETCloseJenna Laine covers...

U.S. oil reserves near 40-year low at 365 million barrels

Oil reserves fell by 9.1 million barrels last week...

Energy & Utilities Roundup: Market Talk

Find insight on oil futures and Seatrium in the...